"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 10 | 10 |
| 2003 | 1 | 7 | 8 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 11 | 11 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 10 | 10 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 3 | 3 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 10 | 10 |
| 2017 | 0 | 9 | 9 |
| 2018 | 0 | 5 | 5 |
| 2019 | 0 | 8 | 8 |
| 2020 | 0 | 8 | 8 |
| 2021 | 0 | 8 | 8 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Pramar YV. Microbiological Stability of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol Oral Liquids Compounded in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):316-320.
-
Pramar YV, Davis C, Ip K, Banov D. Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):321-328.
-
Pramar YV, Mandal TK, Bostanian LA, Johnson J, Graves RA. Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):334-343.
-
Quelch D, Copland A, Kaur J, Sarma N, Appleyard C, Nevill A, Davies N, Knight T, Williams G, Roderique-Davies G, John B, Bradberry S. Oral ethanol prescribing for alcohol withdrawal syndrome: initial findings and future directions following implementation within a United Kingdom National Health Service setting. Clin Toxicol (Phila). 2024 Jul; 62(7):432-440.
-
Pujol A, Sanchis P, Tamayo MI, Nicolau J, Grases F, Espino A, Estremera A, Rigo E, Amengual GJ, Rodr?guez M, Ribes JL, Gomila I, Sim?-Servat O, Masmiquel L. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial). Front Endocrinol (Lausanne). 2024; 15:1332237.
-
Khan M, Hearn K, Parry C, Rashid M, Brim H, Ashktorab H, Kwabi-Addo B. Mechanism of Antitumor Effects of Saffron in Human Prostate Cancer Cells. Nutrients. 2023 12 28; 16(1).
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Jul-Aug; 27(4):330-339.
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Mar-Apr; 27(2):160-168.
-
Lee HJ, Kim HK, Kim BS, Han KD, Park CS, Rhee TM, Park JB, Lee H, Kim YJ. Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment. Sci Rep. 2023 02 04; 13(1):2060.
-
Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022 11; 351:504-559.